Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Mond

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Protocols in Immunology|April 25, 2008
Proliferative assays for B cell functionJames J Mond, Mark Brunswick
The Journal of Antimicrobial Chemotherapy|September 13, 2007
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse modelJohn F Kokai-Kun, Tanya Chanturiya, James J Mond
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized miceJohn F Kokai-Kun, Tanya Chanturiya, James J Mond
Antimicrobial Agents and Chemotherapy|October 25, 2003
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfacesJulie A Wu, Caroline Kusuma, James J Mond, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2003
Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat modelJohn F Kokai-Kun, Scott M Walsh, Tanya Chanturiya, et al.
Infection and Immunity|July 25, 2006
Identification of antigenic components of Staphylococcus epidermidis expressed during human infectionMohammad R Pourmand, Simon R Clarke, Richard F Schuman, et al.
Cellular Immunology|June 1, 2005
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activityGoutam Sen, Michael Flora, Gouri Chattopadhyay, et al.
Journal of Virology|December 3, 2003
Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvantGregory A Prince, James J Mond, David D Porter, et al.
Journal of Bacteriology|November 23, 2006
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureusKate Cosgrove, Graham Coutts, Ing-Marie Jonsson, et al.
Cell Host & Microbe|November 17, 2007
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skinSimon R Clarke, Ramlan Mohamed, Li Bian, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Protocols in Immunology|April 25, 2008
Proliferative assays for B cell functionJames J Mond, Mark Brunswick
The Journal of Antimicrobial Chemotherapy|September 13, 2007
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse modelJohn F Kokai-Kun, Tanya Chanturiya, James J Mond
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized miceJohn F Kokai-Kun, Tanya Chanturiya, James J Mond
Antimicrobial Agents and Chemotherapy|October 25, 2003
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfacesJulie A Wu, Caroline Kusuma, James J Mond, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2003
Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat modelJohn F Kokai-Kun, Scott M Walsh, Tanya Chanturiya, et al.
Infection and Immunity|July 25, 2006
Identification of antigenic components of Staphylococcus epidermidis expressed during human infectionMohammad R Pourmand, Simon R Clarke, Richard F Schuman, et al.
Cellular Immunology|June 1, 2005
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activityGoutam Sen, Michael Flora, Gouri Chattopadhyay, et al.
Journal of Virology|December 3, 2003
Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvantGregory A Prince, James J Mond, David D Porter, et al.
Journal of Bacteriology|November 23, 2006
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureusKate Cosgrove, Graham Coutts, Ing-Marie Jonsson, et al.
Cell Host & Microbe|November 17, 2007
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skinSimon R Clarke, Ramlan Mohamed, Li Bian, et al.
Pageof 2